Invesco Ltd. Entrada Therapeutics, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.85 - $16.45 $418,826 - $581,408	35,344 Added 349.53%	45,456 $647,000
Q1 2024 May 14, 2024	SELL	$11.58 - $17.0 $83,190 - $122,128	-7,184 Reduced 41.54%	10,112 $143,000
Q4 2023 Feb 12, 2024	BUY	$11.36 - $16.99 $196,482 - $293,859	17,296 New	17,296 $260,000
Q3 2022 Nov 14, 2022	BUY	$9.65 - $15.76 $918,766 - $1.5 Million	95,209 New	95,209 $1.5 Million

103

28.2M

34.5K

16.4K

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $423M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.